Waldencast (WALD) Expected to Announce Earnings on Tuesday

Waldencast (NASDAQ:WALD) is anticipated to announce its earnings results after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $70.43 million for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Waldencast Stock Performance

Waldencast stock opened at $3.21 on Monday. The firm’s 50 day simple moving average is $3.24 and its 200 day simple moving average is $3.47. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. Waldencast has a 1-year low of $2.41 and a 1-year high of $7.54.

Wall Street Analysts Forecast Growth

A number of research firms have commented on WALD. TD Cowen began coverage on shares of Waldencast in a research note on Monday, December 16th. They issued a “hold” rating and a $4.30 price target for the company. Telsey Advisory Group reissued an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a research note on Tuesday, March 11th. DA Davidson boosted their price target on shares of Waldencast from $7.25 to $7.50 and gave the stock a “buy” rating in a research note on Wednesday, December 4th. Finally, Canaccord Genuity Group boosted their price target on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, November 22nd. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $5.76.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.